Please login to the form below
real-world data
This page shows the latest real-world data news and features for those working in and with pharma, biotech and healthcare.
Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
Study included around 1.2 million people in Israel. A major real-world study including around 1.2 million people has found the Pfizer/BioNTech vaccine to be 94% effective following ... Earlier this week, real-world data from the UK found that one dose of
Latest news
-
First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
COVID-19 vaccines are also reducing risk of hospitalisation. New real-world data from the UK has found a significant decrease in COVID-19 infections among healthcare workers who have received ... PHE is also looking at the real-world impact of the
-
Verily and Janssen to collaborate on home-based COVID-19 immune response study
Researchers will collect biological measurements, clinical and epidemiological data at the time of COVID-19 testing. ... The researchers will also collect real-world data from participants from up to two years prior to enrolment in the study and up to
-
Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda
As part of the alliance, members are sharing clinical trial data and real-world evidence, as well as crowd-sourcing early-stage candidates to identify mechanisms or treatments that could be ... COVID is not confined to one country, making it imperative
-
Roche’s Ocrevus boasts positive long-term data in MS
The new data comes from the open-label phase 3b CASTING study and the CONFIDENCE real-world safety study, in which Ocrevus was administered to RRMS patients who had experienced a ... New real-world OCREVUS data shows high persistence and adherence to the
-
AbbVie, Amgen and Takeda team up for joint COVID-19 trial
coronavirus. As part of the alliance, members are sharing clinical trial data and real-world evidence, as well as crowd-sourcing early-stage candidates to identify mechanisms or treatments that could ... The world learned of COVID-19 only six months ago,
More from news
Approximately 13 fully matching, plus 114 partially matching documents found.
Latest Intelligence
-
Medicinal data – what’s next for IDMP?
Hindsight is a wonderful thing, and we are not there yet, but COVID-19 has helped to crystallise the potential of data standards, such as IDMP, in real-world use cases, ... EU-wide agreement on data exchange between regulators and industry would be ideal,
-
2021: the year of decentralisation in drug development
Further, trials using decentralised elements capture real-world data from patients’ everyday lives, dramatically improving the quality of data collected on the impact of therapies in a population. ... What’s more, emerging innovations such as AI and
-
Digitising healthcare
Data can be accessible to clinical teams in real time, allowing them to monitor a range of key indicators such as glucose levels, temperature, heart rate, blood pressure and other key ... There must be real checks and measures, along with known baselines
-
COVID-19 – a catalyst for technology adoption in clinical trials
For example, uMotif, a company in the AlbionVC portfolio with a suite of electronic patient data capture tools for real-world and interventional clinical research, has seen a surge in demand ... Another example is our portfolio company Cisiv, which
-
Encouraging patient participation in real-world studies
By Bill Row, Bruce Capobianco and Maggie Adamski. With a variety of sources available, including electronic health records and devices to collect data directly from patients, real-world data (RWD) is ... How can companies encourage patient participation
More from intelligence
Approximately 7 fully matching, plus 70 partially matching documents found.
Latest appointments
-
Astellas appoints new senior VP
pioneered multiple real-world data endeavours and built research partnerships with academic and managed care organisations.
-
Dr Ameet Nathwani moves from Novartis to Sanofi
Oliver Brandicourt, Sanofi's chief executive officer, said: “Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Covid-19: how is it affecting prescribing patterns?
Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas. ... InFormulary XD is a cloud-based platform that enables users to gather data and real-world evidence on formularies and see how their product
-
Wilmington Healthcare launches new platform to map the formulary landscape
Known as InFormulary XD, the solution uses a unique blend of data and real-world evidence to provide an objective view of the status of a product by indication, on formularies ... competition. This level of insight, combined with related stakeholder data,
-
Real-world evidence: breaking boundaries in rare disease
Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid. ... Sonal Bhatia, Vice President, Medical Affairs Rare Disease at Pfizer, explains
-
The patient journey: A long and winding road
In our work at Porterhouse Insights, we often use real-world data (such as patient case records) and choice-based experimental paradigms, and supplement the numbers with rich qualitative data. ... At Porterhouse Insights, our research over the last 8
-
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
Better connecting communities of physicians through education and hubs. Leveraging real-world data and patient experience data (e.g. ... Leverage real-world data to identify patients and facilitate clinical trial recruitment.
More from PMHub
Approximately 3 fully matching, plus 49 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- STEM Healthcare founder Rob Wood secures a 25% stake in performance-io
- Sinopharm’s COVID-19 vaccine scores approval in China
- Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Gene Editing and Precision Medicine: The Future of Healthcare?
- CRM Design and Optimization for Life Science Organizations
- EMA begins rolling review process for Sputnik V COVID-19 vaccine
- MHRA to fast-track vaccines modified for new COVID-19 variants
- Pfizer’s ALK inhibitor Lorbrena scores expanded FDA approval for first-line NSCLC
- Syneos Health Communications announces senior hires to Europe-based team
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
- A cultural shift in clinical research
- Research organisations across the board are experimenting with new technologies...
Quick links
Infographics
